The assessment of other immune cell populations in the tumor showed that in both models, the P2Et/P2Et groups had increased proportions of tumor-infiltrating MDSC-LC (27) and a higher number of CD4+ and CD8+ T cells than the other groups (Figure 3I). The gene discussed is CD4; the disease is neoplasm.